![]() |
||
| Equity : | 100.00% | |
The most aggressive of the static portfolios, the Future Trends
Portfolio invests in sector funds and is intended for investors with a
long investing horizon and a high risk tolerance. This portfolio also
seeks to enhance performance by allowing allocation changes to its
underlying funds, within targeted investment ranges to reflect the
investment manager's outlook.
Investment Range:
33.0-39.0% T. Rowe Price Science and Technology Fund
30.0-36.0% T. Rowe Price Health and Sciences Fund
28.0-34.0% T. Rowe Price Financial Services Fund
| as of November 28, 2008 | ||
|---|---|---|
| T. Rowe Price Financial Services Fund | 34.24 | |
| T. Rowe Price Science & Technology Fund | 33.96 | |
| T. Rowe Price Health Sciences Fund | 31.80 | |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Maximum Sales Charges: Class A: 5.25% up front sales charge Class B: 5.00% contingent deferred sales charge (decreasing over 6 years) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The performance data presented represents past performance. Past performance is not a guarantee of future results and current performance may be lower or higher than the performance quoted. Investment returns in John Hancock Freedom 529 portfolios and the value of an investor’s units will fluctuate and may be worth more or less than original cost when redeemed. Performance current to the most recent month end is available by clicking here.
For more information, including investment policies, charges, and expenses, ask your financial consultant for a Plan Disclosure Document. Please read the Plan Disclosure Document carefully before you invest or send money.